Document Details

  • Form: 4
  • Filing Date: January 31, 2019
  • Document Date: January 25, 2019
  • Form Description: Statement of changes in beneficial ownership of securities
  • Filing Group: 3-4-5
  • Company: Verrica Pharmaceuticals
  • Filer: OCLASSEN GLENN A

Filing Formats